Skip to content

HPV/Genital Warts Health Center

HPV Vaccine Gardasil OK'd for Boys

FDA Approves Gardasil to Help Prevent Genital Warts in Boys and Young Men
Font Size
A
A
A
By
WebMD Health News
Reviewed by Louise Chang, MD

Oct. 16, 2009 -- The FDA has approved the vaccine Gardasil to help prevent genital warts in boys and young men.

Gardasil is now approved for males ages 9 to 26 for the prevention of genital warts caused by two human papillomavirus (HPV) strains: HPV 6 and HPV 11.Those are two of the four HPV strains that Gardasil targets.

In September, an FDA advisory panel recommended Gardasil's approval to prevent genital warts in boys and young men. The vaccine wasn't up for consideration to help prevent cancer in males or to curb transmission of the HPV virus, which is sexually transmitted, to women.

Gardasil is not yet on the CDC's schedule of recommended vaccines for males. The CDC's Advisory Committee on Immunization Practices will discuss that possibility at a meeting next week.

Gardasil, which is made by the drug company Merck, already has FDA approval for use in girls and young women ages 9 to 26. In females, HPV can cause cervical cancer.

Today on WebMD

HPV Vaccine Future
Article
STD Overview
Slideshow
 
STD Facts Quiz
Quiz
Syringes and graph illustration
Tool
 
Sex Drive Killers
Slideshow
Genital Herpes Risks Quiz
Quiz
 
Young couple holding hands
Quiz
Herpes Vaccine Study
Video
 
Condom Quiz
Quiz
HPV Symptoms Tests
Article
 
Get The STD Picture
Feature
cancer cell
Slideshow
 

WebMD Special Sections